Gastrointestinal cancer

Market Spotlight: Gastrointestinal Stromal Tumor (GIST)

This Market Spotlight report covers the Gastrointestinal Stromal Tumor (GIST) market, comprising key marketed and pipeline drugs, recent events and analyst opinion, clinical trials, upcoming and regulatory events, probability of success, patent information, a 10-year disease incidence forecast, licensing and asset acquisition deals, and drug-specific revenue forecasts.

October 21, 2020

Find out more

Hepatocellular carcinoma (HCC) Disease Coverage Forecast and Market Analysis to 2038

Market Spotlight: Pancreatic Cancer

$1,318.00

This Market Spotlight report covers the pancreatic cancer market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability of success, patent information, a 10-year disease incidence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.

September 22, 2020

Find out more

Market Spotlight: Esophageal Cancer

$1,318.00

This Market Spotlight report covers the esophageal cancer market, comprising key marketed and pipeline drugs, clinical trials, upcoming and regulatory events, recent events and analyst opinion, probability of success, a 10-year disease incidence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.

September 3, 2020

Find out more

Gastric Cancer Forecast and Market Analysis

Stomach or gastric cancer (GC) refers to any cancer arising in the lining of the stomach. The vast majority (95%) of these cancers are adenocarcinomas, and can be further grouped by anatomic origin. The clearest etiological distinction exists between adenocarcinomas of the gastric cardia (the anterior edge of the stomach surrounding the entry point of the esophagus), and those arising in the other anatomical subsites of the stomach – the fundus, body, pylorus, and the antrum. In most cases, gastric adenocarcinomas will begin in the muscularis mucosae and submucosa, then invading deeper lamina of the gastric wall.

August 5, 2020

Find out more

Market Spotlight: Gastrointestinal Stromal Tumor (GIST)

Hepatocellular carcinoma (HCC) Disease Coverage Forecast and Market Analysis to 2038

Market Spotlight: Pancreatic Cancer

Market Spotlight: Esophageal Cancer

Gastric Cancer Forecast and Market Analysis

Colorectal Cancer Forecast and Market Analysis